Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric

Haichao Zhang1, Haoran Wang2, Li Ye3

  • 1Department of Osteoporosis and Bone Disease, Research Section of Geriatric Metabolic Bone Disease, Huadong Hospital Affiliated to Fudan University, Shanghai Geriatric Institute, Shanghai, 200032, China.

BMC Cancer
|May 18, 2023
PubMed

Insights

Histone lysine demethylases (KDMs) influence tumor microenvironment (TME) in gastric cancer (GC). A new KDM-based risk score predicts patient outcomes and response to immunotherapy and chemotherapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Histone lysine demethylases (KDMs) play roles in various cancers by regulating gene transcription.
  • The specific involvement of KDMs in the gastric cancer (GC) tumor microenvironment (TME) formation is not well understood.

Purpose of the Study:

  • To comprehensively analyze the relationship between KDMs and TME in gastric cancer.
  • To develop a predictive model for patient prognosis and treatment response based on KDM expression.

Main Methods:

  • Utilized transcriptomic data from TCGA-STAD for analysis of 24 KDMs.
  • Applied Non-negative Matrix Factorization (NMF) for molecular subtyping.
  • Employed ssGSEA and CIBERSORT for TME immune cell infiltration assessment.
  • Developed a KDM-based risk score (KDM_score) for outcome prediction.

Main Results:

  • Identified three distinct KDM-related molecular subtypes in GC with unique clinicopathological and prognostic features.
  • Established a robust KDM-related risk score and nomogram for predicting GC patient outcomes.
  • Demonstrated that a lower KDM-related risk score correlates with better response to immunotherapy and chemotherapy.

Conclusions:

  • Characterized three KDM-related TME patterns in GC, each associated with distinct immune infiltration and prognosis.
  • The developed risk score aids clinicians in predicting patient outcomes and personalizing anticancer treatment strategies, including immunotherapy and chemotherapy.
  • Highlights the potential of KDMs as therapeutic targets and biomarkers in gastric cancer.